These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18625414)

  • 21. Fatigue of muscles weakened by death of motoneurons.
    Thomas CK; Zijdewind I
    Muscle Nerve; 2006 Jan; 33(1):21-41. PubMed ID: 16025525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of amyotrophic lateral sclerosis (ALS) by the family nurse practitioner: a timeline for anticipated referrals.
    Davis M; Lou JS
    J Am Acad Nurse Pract; 2011 Sep; 23(9):464-72. PubMed ID: 21899641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database.
    Miller RG; Anderson F; Brooks BR; Mitsumoto H; Bradley WG; Ringel SP;
    Ann Neurol; 2009 Jan; 65 Suppl 1():S24-8. PubMed ID: 19191307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory effects of amyotrophic lateral sclerosis: problems and solutions.
    Lechtzin N
    Respir Care; 2006 Aug; 51(8):871-81; discussion 881-4. PubMed ID: 16867198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
    Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in cortically induced inhibition in amyotrophic lateral sclerosis with time.
    Attarian S; Pouget J; Schmied A
    Muscle Nerve; 2009 Mar; 39(3):310-7. PubMed ID: 19208411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyotrophic lateral sclerosis: a comprehensive rehabilitation approach.
    Janiszewski DW; Caroscio JT; Wisham LH
    Arch Phys Med Rehabil; 1983 Jul; 64(7):304-7. PubMed ID: 6860106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor responses of the sternocleidomastoid muscle in patients with amyotrophic lateral sclerosis.
    Pinto S; de Carvalho M
    Muscle Nerve; 2008 Oct; 38(4):1312-7. PubMed ID: 18785186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis.
    Sanjak M; Brinkmann J; Belden DS; Roelke K; Waclawik A; Neville HE; Ringel SP; Murphy JR; Brooks BR
    J Neurol Sci; 2001 Oct; 191(1-2):55-9. PubMed ID: 11676992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Functional scales and motor assessment in amyotrophic lateral sclerosis].
    Benaïm C; Desnuelle C; Fournier-Méhouas M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S131-4S137. PubMed ID: 17128101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Symptomatic treatments in amyotrophic lateral sclerosis].
    Clavelou P; Guy N
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S228-4S234. PubMed ID: 17128116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The amyotrophic lateral sclerosis center: a model of multidisciplinary management.
    Mayadev AS; Weiss MD; Distad BJ; Krivickas LS; Carter GT
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):619-31, xi. PubMed ID: 18625420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy for symptomatic relief in amyotrophic lateral sclerosis].
    Cintas P
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S235-4S243. PubMed ID: 17128117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing quality of life in ALS.
    Bromberg MB
    J Clin Neuromuscul Dis; 2007 Dec; 9(2):318-25. PubMed ID: 18090686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiology of fatigue in amyotrophic lateral sclerosis.
    Sharma KR; Kent-Braun JA; Majumdar S; Huang Y; Mynhier M; Weiner MW; Miller RG
    Neurology; 1995 Apr; 45(4):733-40. PubMed ID: 7723963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Petropoulou O; Zis V; Sfagos C; Vassilopoulos D
    In Vivo; 2008; 22(1):137-41. PubMed ID: 18396796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of strength in amyotrophic lateral sclerosis].
    Campana-Salort E
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S138-4S144. PubMed ID: 17128102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amyotrophic lateral sclerosis].
    Kohler A; Genoud D; Magistris MR
    Rev Med Suisse Romande; 1999 Jun; 119(6):497-502. PubMed ID: 10422476
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of physical therapy and occupational therapy in the treatment of amyotrophic lateral sclerosis.
    Lewis M; Rushanan S
    NeuroRehabilitation; 2007; 22(6):451-61. PubMed ID: 18198431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.